IL6 and osteoporosis: After 3 months of ST treatment, the IL-6 and TNF-α levels of the rats in the OVX+ST group were reduced, and the TGF-β1 content was higher than model rats, indicating that ST can improve osteoporosis, which the effect is slightly lower than ALE.